Cooper Financial Group’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $591K | Buy |
1,127
+369
| +49% | +$194K | 0.07% | 219 |
|
|
2025
Q1 | $480K | Buy |
758
+225
| +42% | +$143K | 0.06% | 243 |
|
|
2024
Q4 | $380K | Sell |
533
-66
| -11% | -$47.1K | 0.05% | 269 |
|
|
2024
Q3 | $630K | Buy |
599
+320
| +115% | +$336K | 0.08% | 207 |
|
|
2024
Q2 | $293K | Buy |
+279
| New | +$293K | 0.04% | 304 |
|
|
2022
Q2 | – | Sell |
-553
| Closed | -$386K | – | 279 |
|
|
2022
Q1 | $386K | Buy |
+553
| New | +$386K | 0.15% | 138 |
|